Nevertheless, another group has reported that IFN‐γ can downregulate the antitumor immune response by promoting regulatory T‐cell (Treg) function and suppressing effector T‐cell function via enhancement of indoleamine 2,3‐dioxygenase secretion from cancer cells and antigen‐presenting cells.19 This evidence concerns the gene IFNG and cancer.